cpg glp-1 news From 'companion foods' to 'Nature's Ozempic.' Big food & GLP-1 Drugs Are Reshaping CPG

It's a fair question

The aberrant activation of Nrf2 in cancer cells leads to increased expression of Glucose-6-phosphate dehydrogenase (G6PD), transketolase (TKT), 6-phosphogluconate dehydrogenase (PGD), and other metabolic enzymes promoting glutamine and glucose metabolism in pentose phosphate pathway (PPP) and increasing synthesis of amino acids participating in metabolic reprogramming required for cell proliferation (Mitsuishi et al

10.1002/mas.21858 34 LebedeM.Di MarcoF.Esser-SkalaW.HennigR.WohlschlagerT.HuberC

I think its important to note, however, that this does not invalidate the initial weight loss or the potential popularity of these drugs - nor the chances that patients may stay on them indefinitely

Environ Pollut 230:320328

Peptidomics: Methods and Applications (Wiley, 2007)